Follow
Dr. Santosh Taur, MD, DM
Dr. Santosh Taur, MD, DM
Director Medical Affairs, Vaccines & Digital, Pfizer Limited
Verified email at pfizer.com
Title
Cited by
Cited by
Year
A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions
MN Belhekar, SR Taur, RP Munshi
Indian journal of pharmacology 46 (1), 117-120, 2014
1522014
Proteomic Investigation of Falciparum and Vivax Malaria for Identification of Surrogate Protein Markers
S Ray, D Renu, R Srivastava, K Gollapalli, S Taur, T Jhaveri, S Dhali, ...
Public Library of Science 7 (8), e41751, 2012
672012
Serum proteome analysis of vivax malaria: An insight into the disease pathogenesis and host immune response
S Ray, KS Kamath, R Srivastava, D Raghu, K Gollapalli, R Jain, SV Gupta, ...
Journal of proteomics 75 (10), 3063-3080, 2012
552012
Serum profiling of leptospirosis patients to investigate proteomic alterations
R Srivastava, S Ray, V Vaibhav, K Gollapalli, T Jhaveri, S Taur, S Dhali, ...
Journal of proteomics 76, 56-68, 2012
412012
Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs.
SR Taur, NB Kulkarni, PP Gandhe, BK Thelma, SH Ravat, NJ Gogtay, ...
Journal of Postgraduate Medicine 60 (3), 2014
312014
Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients
AN Thakkar, SR Bendkhale, SR Taur, NJ Gogtay, UM Thatte
Neurology India 60 (6), 577-580, 2012
302012
Use of computerized tests to evaluate psychomotor performance in children with specific learning disabilities in comparison to normal children
S Taur, S Karande, AA Saxena, NJ Gogtay, UM Thatte
Indian Journal of Medical Research 140 (5), 644-648, 2014
262014
Survey of ethics committee protocol approval letters: Compliance with Schedule Y/ICMR guidelines 2006
SR Taur, SB Bavdekar, UM Thatte
A study of warning letters issued to clinical investigators and …, 2011
192011
An audit of therapeutic drug monitoring services of anticonvulsants at a tertiary care hospital in India
SR Taur, NB Kulkarni, NJ Gogtay, UM Thatte
Therapeutic drug monitoring 35 (2), 183-187, 2013
162013
Establishing institutional ethics committees: challenges and solutions–a review of the literature
SK mUKTA, SR Taur, U m THATTE
Indian Journal of Medical Ethics 11 (3), 2014
142014
Observational designs for real-world evidence studies
SR Taur
Perspectives in Clinical Research 13 (1), 12-16, 2022
102022
Survey of ethics committee protocol approval letters: Compliance with Schedule Y
SR Taur, SB Bavdekar, UM Thatte
ICMR guidelines, 214-6, 2006
102006
A Multicenter Evaluation of Overall Susceptibility and Antimicrobial Resistance Among Streptococcus pneumoniae Isolates
N Kulkarni, A Routray, S Taur
Cureus 15 (7), 2023
22023
Anticoagulation for Stroke Prevention of Concomitant Atrial Fibrillation and End-Stage Renal Disease: Insights of Cardiologists and Nephrologists From India
ES Swetha, S Taur, N Kulkarni
Cureus 14 (12), 2022
12022
Cost-effectiveness of apixaban versus other oral anticoagulants and aspirin for stroke prevention in atrial fibrillation in indian subcontinent
N Kulkarni, S Taur, E Tichy, T Kongnakorn, R Sharma
European Heart Journal 43 (Supplement_1), ehab849. 022, 2022
12022
The Year Ahead: An initiative to assess the impact of an intervention “Speaking Book” on awareness among the potential participants about clinical trials in India
U Thatte, S Taur
Perspectives in Clinical Research 2 (3), 83, 2011
12011
EE440 Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Indian Adults Aged≥ 60 Years
N Kulkarni, A Averin, S Taur, L Huang, D Hariharan, M Atwood, N Gupta
Value in Health 26 (12), S136, 2023
2023
‘Oxidative stress’-A new target in the management of diabetes mellitus
AK Das, S Kalra, H Punyani, S Deshmukh, S Taur
Journal of Family Medicine and Primary Care 12 (11), 2552-2557, 2023
2023
A Cardiologists’ Survey on the Use of Anticoagulants and Antiplatelets in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Those Undergoing Percutaneous …
N Kulkarni, S Taur, J Kaur, R Akolekar, ES Swetha
Cureus 15 (2), 2023
2023
Safety of apixaban in Indian patients undergoing elective total knee replacement or total hip replacement surgery: A multi-center, phase-IV study
H Panchal, A Agashe, PK Sancheti, NB Kulkarni, SR Taur
SAGE Open Medicine 9, 20503121211049962, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20